Last reviewed · How we verify

Influenza Fluzone vaccine — Competitive Intelligence Brief

Influenza Fluzone vaccine (Influenza Fluzone vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: inactivated influenza vaccine. Area: Immunology.

marketed inactivated influenza vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

Influenza Fluzone vaccine (Influenza Fluzone vaccine) — La Jolla Institute for Immunology. Fluzone is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against circulating influenza virus strains.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Influenza Fluzone vaccine TARGET Influenza Fluzone vaccine La Jolla Institute for Immunology marketed inactivated influenza vaccine
High-Dose Quadrivalent Influenza Vaccine High-Dose Quadrivalent Influenza Vaccine Tor Biering-Sørensen marketed Inactivated influenza vaccine
FluarixTM FluarixTM GlaxoSmithKline marketed inactivated influenza vaccine
Standard-Dose Influenza Vaccine Standard-Dose Influenza Vaccine Tor Biering-Sørensen marketed Inactivated influenza vaccine
TIV TIV Folia Biotech Inc. marketed Inactivated influenza vaccine
Trivalent Influenza Vaccine Trivalent Influenza Vaccine MedImmune LLC marketed Inactivated influenza vaccine
Fluad Vaccine Fluad Vaccine David H. Canaday marketed Inactivated influenza vaccine with adjuvant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (inactivated influenza vaccine class)

  1. Seqirus · 3 drugs in this class
  2. Center for Disease Prevention and Control of Beijing Military Region · 2 drugs in this class
  3. Sanofi Pasteur, a Sanofi Company · 2 drugs in this class
  4. Sinovac Biotech Co., Ltd · 2 drugs in this class
  5. La Jolla Institute for Immunology · 1 drug in this class
  6. Mount Sinai Hospital, Canada · 1 drug in this class
  7. National Institute of Allergy and Infectious Diseases (NIAID) · 1 drug in this class
  8. University of Sao Paulo · 1 drug in this class
  9. GlaxoSmithKline · 1 drug in this class
  10. University of Witwatersrand, South Africa · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Influenza Fluzone vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/influenza-fluzone-vaccine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: